EQ
EQ
NASDAQ · Biotechnology

Equillium Inc

$1.52
+0.04 (+2.70%)
As of Feb 8, 2:12 PM ET ·
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 35.55M 33.75M 28.19M
Net Income 3.58M 3.41M 3.47M
EPS
Profit Margin 10.1% 10.1% 12.3%
Rev Growth -9.4% +19.8% -2.2%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 6.93M 6.88M 5.91M
Total Equity 59.04M 54.02M 49.55M
D/E Ratio 0.12 0.13 0.12
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA 5.92M 5.34M 5.16M
Free Cash Flow 3.84M 3.54M 2.49M